In clinical research settings, amylin-based therapies have been associated with reduced food intake and meaningful weight loss when paired with lifestyle changes
In addition to Ozempic, this warning also exists for Mounjaro (tirzepatide) and other semaglutide products Wegovy and Rybelsus
mean BMI, 38.5 kg/m 2 ) with overweight or obesity treated with semaglutide for 3 months or longer from January 2021 to March 2023
In rare cases, semaglutide can cause serious side effects that require medical attention, including: Pancreatitis (inflammation of the pancreas) Diabetic retinopathy (vision loss or damage) Severe hypoglycemia (low blood sugar) Increased heart rate Kidney problems Gallbladder problems An allergic reaction Depression or suicidal thoughts If you start to notice signs of any of the aboveincluding difficulty breathing or swallowing, severe rash or itching, feeling faint, changes in your vision, or severe stomach painstop taking semaglutide and contact a healthcare provider immediately
Reading reviews and verifying certifications can aid in identifying reliable sources